|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and hypoxia in rat proximal tubular cells
1 Division of Nephrology, Hypertension and Transplantation, University of Florida, Gainesville, FL, USA; Division of Nephrology-Medicine, Baylor College of Medicine, Houston, TX, USA
2 Division of Nephrology-Medicine, Baylor College of Medicine, Houston, TX, USA
3 Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia
4 Division of Nephrology, Ewha women's University Hospital, Seoul, Korea, Republic of
5 Scios Inc., Sunnyvale, CA, USA
* To whom correspondence should be addressed. E-mail: nakagt{at}medicine.ufl.edu.
Abstract VEGF expression by proximal tubular epithelial cells may play a critical role in maintaining peritubular capillary endothelium in renal disease. Two major processes
involved in renal injury include hypoxia (from vasoconstriction or vascular injury) and
TGF-
dependent fibrosis, both of which are known to stimulate VEGF. Since the TGF-
/Smad pathway is activated in hypoxia, we tested the hypothesis that the induction of VEGF in hypoxia could be partially dependent on TGF-
. Rat proximal tubular (NRK52E) cells treated with TGF-
under normoxic conditions secreted VEGF at 24 hours, and this was significantly reduced by blocking Smad activation by overexpressing the inhibitory Smad7, or by blocking p38 and ERK1/2 MAP kinase
activation or protein kinase C activation with specific inhibitors. With acute hypoxia, rat proximal tubular cells also express VEGF mRNA and protein as well as TGF-
.
However, the induction of VEGF occurs prior to synthesis of TGF-
and is not blocked by either a TGF-
antagonist, by Smad7 overexpression, or by blocking ERK1/2,
whereas induction is blocked by PKC inhibition or partially by p38 inhibitor. Finally, the addition of TGF-
with hypoxia results in significantly more VEGF expression than either stimulation alone. Thus, TGF-
and hypoxia act via additive/synergistic but distinct pathways to stimulate VEGF in proximal tubular cells, a finding which may be important as to how VEGF is stimulated in renal disease.
This article has been cited by other articles:
![]() |
O. Glushakova, T. Kosugi, C. Roncal, W. Mu, M. Heinig, P. Cirillo, L. G. Sanchez-Lozada, R. J. Johnson, and T. Nakagawa Fructose Induces the Inflammatory Molecule ICAM-1 in Endothelial Cells J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1712 - 1720. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Basile, K. Fredrich, B. Chelladurai, E. C. Leonard, and A. R. Parrish Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor Am J Physiol Renal Physiol, April 1, 2008; 294(4): F928 - F936. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grenda, E. Wuhl, M. Litwin, R. Janas, J. Sladowska, K. Arbeiter, U. Berg, A. Caldas-Afonso, M. Fischbach, O. Mehls, et al. Urinary excretion of endothelin-1 (ET-1), transforming growth factor- 1 (TGF- 1) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3487 - 3494. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, W. Sato, O. Glushakova, M. Heinig, T. Clarke, M. Campbell-Thompson, Y. Yuzawa, M. A. Atkinson, R. J. Johnson, and B. Croker Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy J. Am. Soc. Nephrol., February 1, 2007; 18(2): 539 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. de Laplanche, K. Gouget, G. Cleris, F. Dragounoff, J. Demont, A. Morales, L. Bezin, C. Godinot, G. Perriere, D. Mouchiroud, et al. Physiological oxygenation status is required for fully differentiated phenotype in kidney cortex proximal tubules Am J Physiol Renal Physiol, October 1, 2006; 291(4): F750 - F760. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakagawa, W. Sato, Y. Y. Sautin, O. Glushakova, B. Croker, M. A. Atkinson, C. C. Tisher, and R. J. Johnson Uncoupling of Vascular Endothelial Growth Factor with Nitric Oxide as a Mechanism for Diabetic Vasculopathy J. Am. Soc. Nephrol., March 1, 2006; 17(3): 736 - 745. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |